Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Saved in:
| Title: | Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. |
|---|---|
| Authors: | Shain AH; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Garrido M; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Botton T; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Talevich E; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Yeh I; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Sanborn JZ; Five3 Genomics, LLC, Santa Cruz, California, USA., Chung J; Samsung Advanced Institute of Technology, Seoul, Korea., Wang NJ; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA., Kakavand H; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Mann GJ; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Wiesner T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Roy R; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Olshen AB; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Gagnon A; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Gray JW; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA., Huh N; Samsung Advanced Institute of Technology, Seoul, Korea., Hur JS; Samsung Electronics Headquarters, Seoul, Korea., Busam KJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Scolyer RA; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Murali R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bastian BC; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Nature genetics [Nat Genet] 2015 Oct; Vol. 47 (10), pp. 1194-9. Date of Electronic Publication: 2015 Sep 07. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26343386 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shain+AH%22">Shain AH</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Garrido+M%22">Garrido M</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Botton+T%22">Botton T</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Talevich+E%22">Talevich E</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yeh+I%22">Yeh I</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Sanborn+JZ%22">Sanborn JZ</searchLink>; Five3 Genomics, LLC, Santa Cruz, California, USA.<br /><searchLink fieldCode="AU" term="%22Chung+J%22">Chung J</searchLink>; Samsung Advanced Institute of Technology, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Wang+NJ%22">Wang NJ</searchLink>; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Kakavand+H%22">Kakavand H</searchLink>; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Mann+GJ%22">Mann GJ</searchLink>; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+JF%22">Thompson JF</searchLink>; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wiesner+T%22">Wiesner T</searchLink>; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Roy+R%22">Roy R</searchLink>; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Olshen+AB%22">Olshen AB</searchLink>; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Gagnon+A%22">Gagnon A</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Gray+JW%22">Gray JW</searchLink>; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Huh+N%22">Huh N</searchLink>; Samsung Advanced Institute of Technology, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Hur+JS%22">Hur JS</searchLink>; Samsung Electronics Headquarters, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Busam+KJ%22">Busam KJ</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Scolyer+RA%22">Scolyer RA</searchLink>; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Cho+RJ%22">Cho RJ</searchLink>; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Murali+R%22">Murali R</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Bastian+BC%22">Bastian BC</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2015 Oct; Vol. 47 (10), pp. 1194-9. <i>Date of Electronic Publication: </i>2015 Sep 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26343386 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/ng.3382 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1194 Titles: – TitleFull: Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shain AH – PersonEntity: Name: NameFull: Garrido M – PersonEntity: Name: NameFull: Botton T – PersonEntity: Name: NameFull: Talevich E – PersonEntity: Name: NameFull: Yeh I – PersonEntity: Name: NameFull: Sanborn JZ – PersonEntity: Name: NameFull: Chung J – PersonEntity: Name: NameFull: Wang NJ – PersonEntity: Name: NameFull: Kakavand H – PersonEntity: Name: NameFull: Mann GJ – PersonEntity: Name: NameFull: Thompson JF – PersonEntity: Name: NameFull: Wiesner T – PersonEntity: Name: NameFull: Roy R – PersonEntity: Name: NameFull: Olshen AB – PersonEntity: Name: NameFull: Gagnon A – PersonEntity: Name: NameFull: Gray JW – PersonEntity: Name: NameFull: Huh N – PersonEntity: Name: NameFull: Hur JS – PersonEntity: Name: NameFull: Busam KJ – PersonEntity: Name: NameFull: Scolyer RA – PersonEntity: Name: NameFull: Cho RJ – PersonEntity: Name: NameFull: Murali R – PersonEntity: Name: NameFull: Bastian BC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2015 Oct Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1546-1718 Numbering: – Type: volume Value: 47 – Type: issue Value: 10 Titles: – TitleFull: Nature genetics Type: main |
| ResultId | 1 |